Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRIDGE: Bridging Anticoagulation for Surgery
NCT00786474Phase 3Completed
- Sponsor
- Duke University
- Start
- Jul 2009
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dalteparin in Atrial fibrillation (AFib), sponsored by Duke University. Started Jul 2009; status: completed.
02
Drugs
dalteparin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00786474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00786474.